Company / Income Tax
Exelixis Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$158.6M
FY2025
5-year range
$19.1M / $160.4M
FY2021-FY2025
Trend
-1.1%
vs FY2024
Sector context
#17 of 204
Health Care
What the data says
Among 204 Health Care companies, Exelixis is in the bottom 8% for income tax. Income Tax has fluctuated over the past 10 years, ranging from $0 in FY2018 to $160M in FY2024.
Based on SEC 10-K filings.
$159M in FY2025 with a 5-year CAGR of +52.8%. Top quartile in the Health Care sector.
Increased from $50M to $159M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +102.7%
- 5-Year CAGR
- +52.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 204This company $158.6M Sector average $118.7M
▼
+33.6% above sector average
Key checks
Key Insights
- 5-year CAGR of +52.8%, indicating consistent growth.
- In FY2025, income tax decreased 1.1% year-over-year.
- Ranks #17 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $158.6M | -1.1% |
| FY2024 | $160.4M | +222.3% |
| FY2023 | $49.8M | +161.1% |
| FY2022 | $19.1M | -75.3% |
| FY2021 | $77.1M | +304.6% |
| FY2020 | $19.1M | -75.3% |
| FY2019 | $77.1M | - |
| FY2018 | $0 | -100.0% |
| FY2017 | $4.3M | - |
| FY2016 | $0 | -100.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026